Multisite research, including research at UAB, shows that oral semaglutide is nearly as effective as the widely used injectable version for treating obesity, delivering about 13.7 percent average weight loss over 64 weeks.

The combo drug could mark a significant step forward in medical weight management — especially for patients struggling to lose weight through diet and exercise alone.

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

New research finds that a low-carbohydrate diet may improve beta-cell function in people with Type 2 diabetes.

Type 2 diabetes is alarmingly on the rise in Alabama youth, but following a healthy diet and exercising regularly can help mitigate the risk and the severity.